Training experts in Colombia to improve Alzheimer's research and care
Official title: Research Training for Equity in Alzheimer's Disease and Brain Health in Colombia
Funded at University of California, San Francisco · NIH-11063917 · Data updated 2026-11-12
This study is all about helping Universidad Javeriana in Bogotá train local experts in Alzheimer's and related dementias by starting a new Doctorate program that offers support and resources for students, so they can improve research and care for people with these conditions in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | April 1, 2024 |
| Project end | February 28, 2029 |
| Funding year | 2025 |
| Award (this year) | $243,207 |
| NIH project number | 5D43TW012455-02 |
| Project ID | NIH-11063917 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals in Colombia affected by Alzheimer's disease and related dementias.
✕Less likely to help
Patients outside of Colombia or those not affected by Alzheimer's disease or related dementias may not receive benefits from this research.
What this research studies
This research focuses on enhancing the research capabilities of Universidad Javeriana in Bogotá, Colombia, specifically in the area of Alzheimer's disease and related dementias. It aims to train local experts through a new Doctorate of Neuroscience program, which includes coursework in statistics and grant writing. The program will also provide stipends and seed grants to support promising doctoral students, fostering a sustainable research environment. By building on existing collaborations, this initiative seeks to advance research, education, and care for Alzheimer's in low- and middle-income countries.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of Alzheimer's disease in Colombia and similar regions.
How similar studies have gone: Similar initiatives have shown success in enhancing research capacity and improving health outcomes in other low- and middle-income countries.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Valcour, Victor — University of California, San Francisco
- Study coordinator: Valcour, Victor
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.